CE- New Drug Update Quiz CE - New Drug Update ACPE # 0278-0000-15-045-H01-P ACPE # 0278-0000-15-045-H01-T 1Contact2Quiz Name* First Last Email* Phone*Attendee Type* Pharmacist Technician Coagulation factor Xa (recombinant), inactivated-zhzo (andexanet alfa) (Andexxa) is FDA-approved as a reversal agent for which of the following (slides 12-20)?* Rivaroxban (Xarelto) Apixaban Dabigatran (Pradaxa) Enoxaparin (Lovenox) A & B Plazomicin (Zemdri)belongs to which of the following antibiotic classes (slides 30-37)?* Quinolones Tetracyclines Macrolides Aminoglycosides Baricitinib (Olumiant) is a Janus kinase inhibitor that's FDA-approved for which of the following conditions (slides 63-71)?* Psoriasis Inflammatory bowel disease Rheumatoid arthritis Lupus Erenumab-aooe (Aimovig) is a new drug for migraine prophylaxis. How should it be administered (slides 84-91)?* Orally Subcutaneously Intramuscularly Sublingually Sodium Zirconium Cyclosilicate (Lokelma) is a new drug for treating hyperkalemia. What is its most common adverse effect (slides 109-115)?* Hypertension Dehydration Edema Hypercalcemia Tildrakizumab-asmn (Ilumya) is a new drug for treating psoriasis. What is its mechanism of action (slides 127-133)?* Interleukin 12 antagonist Interleukin 17 antagonist Interleukin 23 antagonist TNF inhibitor Δ
